Tuesday, April 21, 2026
Yahoo Finance

Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential

R
Redacción
Newsroom · ayer
2 min read
Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential · DevFinanciero